Skip to main content
SpringerLink
Log in

Drug-Induced Pemphigus

  • Chapter
  • First Online:
European Handbook of Dermatological Treatments

  • 26 Accesses

Abstract

Pemphigus comprises a group of autoimmune bullous diseases characterized by acantholysis (loss of adhesion between keratinocytes) that results in the formation of intraepithelial blisters in the skin and mucous membranes. Multiple drugs are reported to induce pemphigus, most commonly thiol drugs. The mechanisms include autoantibody formation and direct acantholysis. The diagnosis of drug-induced pemphigus is challenging. Patients are often on multiple medications, and the latency period between exposure and onset of disease can be variable. Withdrawal of an offending drug may lead to remission or reduced disease severity in many patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

HLA:

Human leukocyte antigen

IL-1:

Interleukin-1

TNF-α:

Tumor necrosis factor alpha

References

  • Brenner S, Bialy-Golan A, Ruocco V. Drug-induced pemphigus. Clin Dermatol. 1998;16(3):393–7.

    Article  CAS  PubMed  Google Scholar 

  • Goldberg I, Shirazi I, Brenner S. In vitro interferon-gamma release test in patients with drug-induced pemphigus. Isr Med Assoc J. 2008;10(6):424–7.

    PubMed  Google Scholar 

  • Harman KE, Brown D, Exton LS, Groves RW, Hampton PJ, Mohd Mustapa MF, Setterfield JF, Yesudian PD. British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris. Br J Dermatol. 2017;177:1170–201.

    Article  CAS  PubMed  Google Scholar 

  • Joly P, Horvath B, Patsatsi Α, Uzun S, Bech R, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV). J Eur Acad Dermatol Venereol. 2020;34:1900–13.

    Article  CAS  PubMed  Google Scholar 

  • Maruani A, Machet MC, Carlotti A, et al. Immunostaining with antibodies to desmoglein provides the diagnosis of drug-induced pemphigus and allows prediction of outcome. Am J Clin Pathol. 2008;130(3):369–74.

    Article  PubMed  Google Scholar 

  • Nagao K, Tanikawa A, Yamamoto N, Amagai M. Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of D-penicillamine in drug-induced pemphigus foliaceus. Clin Exp Dermatol. 2005;30(1):43–5.

    Article  CAS  PubMed  Google Scholar 

  • Pile HD, Yarrarapu SNS, Crane JS. Drug induced pemphigus. [Updated 2020 Jul 20]. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2020. https://www.ncbi.nlm.nih.gov/books/NBK499864/

    Google Scholar 

  • Ruocco V, Pisani M. Induced pemphigus. Arch Dermatol Res. 1982;274:123–40.

    Google Scholar 

  • Saito Y, Hayashi S, Yamauchi A, et al. Tracing the origins of active amide group-positive drug-induced pemphigus vulgaris along the silk road: a case report of candesartan-induced pemphigus vulgaris and review of nonthiol drug-induced pemphigus. Int J Dermatol. 2018;57(11):e131–4.

    Article  PubMed  Google Scholar 

  • Tang X, Zhang X. Drug-induced pemphigus after six years of treatment with phenytoin and carbamazepine. Int J Dermatol. 2012;51(4):485–6.

    Article  PubMed  Google Scholar 

  • Tavakolpour S. Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol Res. 2018;310(2):95–106.

    Article  PubMed  Google Scholar 

  • Yamamoto T, Takata-Michigami M, Hisamatsu Y, et al. A prospective analysis of anti-desmoglein antibody profiles in patients with rheumatoid arthritis treated with thiol compounds. J Dermatol Sci. 2010;59(3):170–5.

    Article  CAS  PubMed  Google Scholar 

Further Reading

  • Bae YI, Yun SJ, Lee SC, et al. Pemphigus foliaceus induced by an angiotensin II receptor blocker. Clin Exp Dermatol. 2008;33(6):721–3.

    Article  CAS  PubMed  Google Scholar 

  • Brenner S, Bialy-Golan A, Anhalt GJ. Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol. 1997;36(6 Pt 1):919–23.

    Article  CAS  PubMed  Google Scholar 

  • Brenner S, Ruocco V, Ruocco E, et al. A possible mechanism for phenol-induced pemphigus. Skinmed. 2006;5(1):25–6.

    Article  PubMed  Google Scholar 

  • Feng S, Zhou W, Zhang J, Jin P. Analysis of 6 cases of drug-induced pemphigus. Eur J Dermatol. 2011;21(5):696–9.

    Article  CAS  PubMed  Google Scholar 

  • Goldberg I, Sasson A, Gat A, et al. Pemphigus vulgaris triggered by glibenclamide and cilazapril. Acta Dermatovenerol Croat. 2005;13(3):153–5.

    PubMed  Google Scholar 

  • Landau M, Brenner S. Histopathologic findings in drug-induced pemphigus. Am J Dermatopathol. 1997;19(4):411–4.

    Article  CAS  PubMed  Google Scholar 

  • Marsden RA, Vanhegan RI, Walshe M, et al. Pemphigus foliaceus induced by penicillamine. Br Med J. 1976;2(6049):1423–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Matzner Y, Erlich HA, Brautbar C. Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris. Acta Derm Venereol. 1995;75(1):12–4.

    Article  CAS  PubMed  Google Scholar 

  • Ruocco V, De Angelis E, Lombardi ML. Drug-induced pemphigus. II. Pathomechanisms and experimental investigations. Clin Dermatol. 1993;11:507–13.

    Article  CAS  PubMed  Google Scholar 

  • Wolf R, Tamir A, Brenner S. Drug-induced versus drug-triggered pemphigus. Dermatologica. 1991;182(4):207–10.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. N. Farah Mahmood, Atheer Al-Haddabi, and Dushyanth Gnanappiragasam contributed equally to this work.

Authors and Affiliations

  1. University Hospitals of Leicester, Leicester, UK

    Nazipha Farah Mahmood, Atheer Al-Haddabi, Dushyanth Gnanappiragasam & Karen Elizabeth Harman

  2. Mid and South Essex NHS Foundation Trust, Essex, UK

    Olga Golberg

Authors
  1. Nazipha Farah Mahmood
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atheer Al-Haddabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dushyanth Gnanappiragasam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olga Golberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karen Elizabeth Harman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karen Elizabeth Harman .

Editor information

Editors and Affiliations

  1. Andreas Syggros Hospital, Athens State University, Athens, Greece

    Andreas D. Katsambas

  2. Research Center CSRMR, Marconi University, Rome, Roma, Italy

    Torello M. Lotti

  3. Andreas Syggros Hospital, Athens State University, Athens, Greece

    Clio Dessinioti

  4. Dermatoloy Unit, Livorno Hospital, Livorno, Italy

    Angelo Massimiliano D'Erme

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mahmood, N.F., Al-Haddabi, A., Gnanappiragasam, D., Golberg, O., Harman, K.E. (2023). Drug-Induced Pemphigus. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_70

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-15130-9_70

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-15129-3

  • Online ISBN: 978-3-031-15130-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation